Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p4
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 4/22)
Character Range: 259132–262039

preparations containing 0.1% or less calculated as boric acid when labelled with a warning to the following effect:

           NOT TO BE SWALLOWED. NOT TO BE USED FOR CHILDREN UNDER 3 YEARS OF AGE; or
 (e) in other cosmetic preparations containing 3% or less calculated as boric acid when labelled with a warning to the following effect:

           NOT TO BE USED FOR CHILDREN UNDER 3 YEARS OF AGE; and
  if the concentration of free soluble borates exceeds 1.5% (as boric acid), with the words:

           NOT TO BE USED ON PEELING OR IRRITATED SKIN; or
 (f) in preparations, other than insect baits, containing 6% or less calculated as boric acid.
BORON TRIFLUORIDE in preparations containing 0.1% or less of boron trifluoride (BF3).
BROFLANILIDE in preparations containing 0.3% or less of broflanilide.
BROMUCONAZOLE in preparations containing 20% or less of bromuconazole.
BUPIVACAINE in aqueous gel preparations containing 0.5% or less of bupivacaine, for the dermal spray‑on administration to the wounds of animals.
BUPROFEZIN except in preparations containing 40% or less of buprofezin.
BUTHIDAZOLE.
BUTOXYCARBOXIM in solid preparations containing 10% or less of butoxycarboxim.
BUTRALIN.
BUTROXYDIM.
n‑BUTYL ALCOHOL in preparations containing 10% or less of n‑butyl alcohol except:
 (a) in preparations containing 5% or less of n‑butyl alcohol; or
 (b) in preparations for cosmetic or therapeutic use other than spray form.
CAMPHOR as a natural component in essential oils containing 10% or less of camphor except:
 (a) in medicines for human therapeutic use, in essential oils when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in preparations other than medicines for human therapeutic use, in essential oils when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or
 (c) in rosemary oil, sage oil (Spanish), or lavandin oils; or
 (d) in preparations containing 2.5% or less of camphor.
CARBAMIDE PEROXIDE in preparations containing 18% or less of carbamide peroxide except in preparations containing 9% or less of carbamide peroxide.
CARBARYL:
 (a) in preparations containing 10% or less of carbaryl except when included in Schedule 4; or
 (b) when impregnated into plastic resin material containing 20% or less of carbaryl.
CASSIA OIL except:
 (a) in food additives; or
 (b) in preparations for dermal use as a rubefacient containing 5% or less of cassia oil; or
 (c) in other preparations containing 2% or less of cassia oil.
CHLORFENAC.
CHLORFENAPYR. in preparations containing 0.5% or less of chlorfenapyr.
CHLORFENSON.
CHLORHEXIDINE in preparations containing 3% or